Gaush Meditech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	437.66	421.44	618.7	721.52	609
Short-Term Investments	-	-	38.74	90.54	-
Trading Asset Securities	-	97.55	175.53	2.1	-
Cash & Short-Term Investments	437.66	518.99	832.97	814.16	609
Cash Growth	-15.67%	-37.69%	2.31%	33.69%	98.05%
Receivables	163.71	167.7	149.09	168.64	171.99
Inventory	345.45	334.42	328.53	281.12	240.11
Other Current Assets	134.78	129.66	80.25	62.41	68.69
Total Current Assets	1,082	1,151	1,391	1,326	1,090
Property, Plant & Equipment	144.67	124.01	126.08	126.75	85.53
Goodwill	993.3	910.51	961.39	906.87	882.7
Other Intangible Assets	287.26	294.42	269.83	278.88	303.89
Long-Term Accounts Receivable	-	-	-	-	0.08
Long-Term Deferred Tax Assets	85.21	47.77	57.01	56.27	40.85
Other Long-Term Assets	32.02	38.83	38.58	22.98	23.84
Total Assets	2,624	2,566	2,844	2,718	2,427
Accounts Payable	81.74	70.34	90.56	68.7	68.02
Short-Term Debt	135.17	-	-	-	84.22
Current Portion of Long-Term Debt	-	170.63	523.27	131.88	38.54
Current Portion of Leases	14.87	20.16	14.32	19.24	12.6
Current Income Taxes Payable	11.19	17.66	5.2	13.58	19.79
Current Unearned Revenue	86.43	103.86	125.46	136.05	93.88
Other Current Liabilities	121.77	129.16	132.86	123.18	124.18
Total Current Liabilities	451.17	511.81	891.67	492.62	441.24
Long-Term Debt	315.15	337.1	95.29	569.71	2,455
Long-Term Leases	41.97	24.35	31.48	35.18	31.78
Long-Term Unearned Revenue	53.88	31.66	29.97	26.89	29.26
Long-Term Deferred Tax Liabilities	51.61	57.15	66.55	71.95	66.37
Other Long-Term Liabilities	13.37	16.06	31.76	35.05	36.54
Total Liabilities	927.15	978.12	1,147	1,231	3,060
Common Stock	0.1	0.1	0.1	0.1	0.07
Retained Earnings	-	1,615	1,672	1,497	-236.83
Treasury Stock	-36.27	-11.69	-	-	-
Comprehensive Income & Other	1,724	-27.82	8.77	-27.07	-419.67
Total Common Equity	1,688	1,575	1,680	1,470	-656.43
Minority Interest	8.96	13.05	16.52	17.13	23.06
Shareholders' Equity	1,697	1,588	1,697	1,487	-633.37
Total Liabilities & Equity	2,624	2,566	2,844	2,718	2,427
Total Debt	507.15	552.24	664.36	756	2,622
Net Cash (Debt)	-69.49	-33.24	168.61	58.16	-2,013
Net Cash Growth	-	-	189.92%	-	-
Net Cash Per Share	-0.48	-0.22	1.14	0.60	-21.00
Filing Date Shares Outstanding	145.48	146.67	147.97	147.93	107.22
Total Common Shares Outstanding	145.48	146.67	147.97	147.93	94.15
Working Capital	630.43	638.96	499.17	833.71	648.55
Book Value Per Share	11.60	10.74	11.36	9.93	-6.97
Tangible Book Value	407.38	370.21	449.25	283.8	-1,843
Tangible Book Value Per Share	2.80	2.52	3.04	1.92	-19.58
Machinery	-	88.78	92.29	68.13	44.44
Construction In Progress	-	18.24	-	4.06	-
Leasehold Improvements	-	32.07	31.67	26.13	14.55

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.